146 related articles for article (PubMed ID: 23777014)
1. [Bactericidal activity of sitafloxacin and other new quinolones against antimicrobial resistant Streptococcus pneumoniae].
Kobayashi I; Kanayama A; Hasegawa M; Kaneko A
Jpn J Antibiot; 2013 Feb; 66(1):25-35. PubMed ID: 23777014
[TBL] [Abstract][Full Text] [Related]
2. Rapid bactericidal activity of sitafloxacin against Streptococcus pneumoniae.
Kanda H; Inoue K; Okumura R; Hoshino K
Jpn J Antibiot; 2013 Feb; 66(1):9-23. PubMed ID: 23777013
[TBL] [Abstract][Full Text] [Related]
3. In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniae.
Fukuda Y; Takahata M; Sugiura Y; Shinmura Y; Nomura N
Int J Antimicrob Agents; 2012 Feb; 39(2):163-7. PubMed ID: 22088660
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones.
Grohs P; Houssaye S; Aubert A; Gutmann L; Varon E
Antimicrob Agents Chemother; 2003 Nov; 47(11):3542-7. PubMed ID: 14576115
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
Adam HJ; Schurek KN; Decorby MR; Weshnoweski B; Vashisht R; Karlowsky K; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2006 Jul; 58(1):202-4. PubMed ID: 16636082
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
[TBL] [Abstract][Full Text] [Related]
7. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
Okumura R; Hirata T; Onodera Y; Hoshino K; Otani T; Yamamoto T
J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of sitafloxacin against clinical isolates in 2012].
Amano A; Matsuzaki K; Kishi N; Koyama H; Hasegawa M; Ikeda F; Matsumoto T; Yamaguchi H; Okutani Y
Jpn J Antibiot; 2013 Dec; 66(6):311-30. PubMed ID: 24649797
[TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of sitafloxacin against clinical isolates in 2009].
Amano A; Matsuzaki K; Kishi N; Saika T; Hasegawa M; Ikeda F; Matsumoto T; Yamaguchi H; Kanda Y; Shiozawa T
Jpn J Antibiot; 2010 Dec; 63(6):411-30. PubMed ID: 21425595
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Resistance Development to Nemonoxacin in Streptococcus pneumoniae: A Unique Profile for a Novel Nonfluorinated Quinolone.
Roychoudhury S; Makin K; Twinem T; Leunk R; Hsu MC
Microb Drug Resist; 2016 Oct; 22(7):578-584. PubMed ID: 27267788
[TBL] [Abstract][Full Text] [Related]
11. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of quinolone-insensitive Streptococcus pneumoniae isolates from Japanese patients.
Araki N; Yanagihara K; Matsukawa Y; Harada Y; Migiyama Y; Nagaoka K; Yamada K; Morinaga Y; Hasegawa H; Kohno S; Kamihira S
J Infect Chemother; 2013 Apr; 19(2):356-9. PubMed ID: 22911090
[TBL] [Abstract][Full Text] [Related]
13. Comparison of drug sensitivity and genotypes of clinically isolated strains of levofloxacin-resistant Streptococcus pneumoniae obtained from Okinawa Island, the Japanese main island and Hong Kong.
Sunagawa S; Fujita J; Higa F; Tateyama M; Haranaga S; Nakasone I; Yamane N; Uno T
J Antibiot (Tokyo); 2011 Aug; 64(8):539-45. PubMed ID: 21587266
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of garenoxacin tested by kill-curve methodology against wild type and QRDR mutant strains of Streptococcus pneumoniae.
Anderegg TR; Jones RN
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):213-7. PubMed ID: 15541608
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility and bactericidal activity of 8 oral quinolones against conventional-fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
Yokota S; Ohkoshi Y; Fujii N
Diagn Microbiol Infect Dis; 2009 Sep; 65(1):76-80. PubMed ID: 19679241
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterisation of the quinolone resistance-determining regions (QRDR) including gyrA, gyrB, parC and parE genes in Streptococcus pneumoniae.
Kakinuma Y; Maeda Y; Mason C; Goldsmith CE; Coulter WA; Matsuda M; Dooley JS; Lowery CJ; Moore JE
Br J Biomed Sci; 2012; 69(3):123-5. PubMed ID: 23057160
[TBL] [Abstract][Full Text] [Related]
17.
Murata M; Kosai K; Yamauchi S; Sasaki D; Kaku N; Uno N; Morinaga Y; Hasegawa H; Miyazaki T; Izumikawa K; Mukae H; Yanagihara K
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439959
[TBL] [Abstract][Full Text] [Related]
18. Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents.
Browne FA; Bozdogan B; Clark C; Kelly LM; Ednie L; Kosowska K; Dewasse B; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2003 Dec; 47(12):3815-24. PubMed ID: 14638489
[TBL] [Abstract][Full Text] [Related]
19. Quinolones with enhanced bactericidal activity induce autolysis in Streptococcus pneumoniae.
Okumura R; Hoshino K; Otani T; Yamamoto T
Chemotherapy; 2009; 55(4):262-9. PubMed ID: 19468224
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic activity of garenoxacin against ciprofloxacin-resistant Streptococcus pneumoniae.
Zhanel GG; James J; Derkatch S; Laing N; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2006 Jul; 58(1):112-6. PubMed ID: 16644764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]